A detailed history of Guerra Advisors Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Guerra Advisors Inc holds 10 shares of NVCR stock, worth $113. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Holding current value
$113
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$10.9 - $18.46 $109 - $184
10 New
10 $129,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Guerra Advisors Inc Portfolio

Follow Guerra Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guerra Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guerra Advisors Inc with notifications on news.